CellaVision and Sysmex Corporation announced a Strategic Alliance Agreement to reinforce and extend their joint leadership position within hematology and seize new opportunities for optimized diagnostics. For 20 years CellaVision and Sysmex have had a successful partnership, and with the Strategic Alliance Agreement the parties expand their mutual commitment until 2038. The expansion enables the companies to further streamline laboratory processes and transform the field of digital cell morphology.

Through the agreement, Cella Vision and Sysmex strengthen the existing relationship by a deeper and broader collaboration within innovation and collaborative commercialization. Sysmex's leading expertise in hematology, combined with CellaVision's advanced imaging solutions and AI-assisted cell classifications, lays the groundwork for the continued innovation of offerings. This will gradually expand the addressable market through a mutual commitment to raise the standard of diagnostic certainty globally.